Thus, there is considerable coexistence of LOY and CHIP in men with chronic heart failure, which is presumably due to the advanced age of the patients studied, as statistical testing failed to establish a significant association between the presence or extent of LOY and DNMT3A/TET2 CHIP‐driver mutations in our cohort. This evidence concerns the gene TET2 and congestive heart failure.